Caricamento...

Lymphoblastic Cell Lines in Pharmacogenomics: How applicable are they in clinical outcomes?

LCLs are widely used in pharmacogenomic studies and the applicability of LCLs for various clinical phenotypes is emerging. Early studies have yielded promising results for LCLs as a proxy for genetic variants for treatment outcome for a number of cancers as well as toxicity in varying tissue types i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Stark, Amy L., Dolan, M. Eileen
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4075127/
https://ncbi.nlm.nih.gov/pubmed/23556440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.13.32
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !